Side-by-side comparison of AI visibility scores, market position, and capabilities
NYSE-listed (GIS) global food company with $19.9B revenue; Cheerios, Betty Crocker, Pillsbury, Blue Buffalo pet food competing with Kellanova and Nestlé while managing GLP-1 drug volume impact.
General Mills is a Minneapolis-based global food company producing packaged foods across breakfast cereals, convenient meals, snacks, baking products, yogurt, and pet food through iconic consumer brands including Cheerios, Wheaties, Betty Crocker, Pillsbury, Yoplait, Nature Valley, Häagen-Dazs, and Blue Buffalo (pet food). Listed on NYSE (NYSE: GIS), General Mills generated approximately $19.9 billion in net sales in fiscal year 2024 (ending May 2024) and employs approximately 33,000 people globally, distributing products in 100+ countries.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.